Autoimmune hepatitis – Update 2015

Slides:



Advertisements
Similar presentations
T -lymphocytes T cell receptor T – cytotoxic (CD8) cells
Advertisements

Cytokines Non-antibody proteins acting as mediators between cells, termed: Monokines – mononuclear phagocytes Lymphokines – activated T cells, especially.
Volume 72, Issue 6, Pages (September 2007)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Mononuclear phagocytes in Immune Defence
Cancer and the Immune System
Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Other Cells of Immune System
Transplant: immunology and treatment of rejection
Immunotherapy of hepatocellular carcinoma
Hepatic CD141+IFNλ+ DC subset: One against all?
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Figure 1 Radiation-induced effects on tumour cells
The yin and yang of evasion and immune activation in HCC
Tumor Immunology Ali Al Khader, MD Faculty of Medicine
Obesity, inflammation, and liver cancer
Volume 57, Issue 1, Pages 6-8 (July 2012)
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
The Th17 immune response in renal inflammation
Volume 49, Issue 5, Pages (November 2008)
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Regulatory T-cell directed therapies in liver diseases
Malaria Vaccine Design: Immunological Considerations
Colorectal cancer vaccines: Principles, results, and perspectives
Gut–liver immunity Journal of Hepatology
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
T –HELPER CELL AMMAR HADI
Volume 69, Issue 4, Pages (October 2018)
From immunosuppression to tolerance
Regulatory T-cell directed therapies in liver diseases
IgG4 cholangiopathy – Current concept, diagnosis, and pathogenesis
Targets for immunotherapy of liver cancer
during the alloimmune response
The yin and yang of evasion and immune activation in HCC
Autophagy and senescence in fibrosing cholangiopathies
Pro-endometriotic niche in endometriosis
Celiac Disease: From Pathogenesis to Novel Therapies
Mechanism of CTLA-4-induced immunosuppression.
Tilo Biedermann, Martin Röcken, José M. Carballido 
De novo autoimmune hepatitis after liver transplantation
EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani
HCMV jogs the ‘memory’ of NK cells in HBV
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Role of IgE in autoimmunity
Cannabinoid signaling and liver therapeutics
Volume 63, Issue 2, Pages (August 2015)
Figure 1 Sequence of events in the development of autoimmune nephritis
Mechanisms of Contact Sensitization Offer Insights into the Role of Barrier Defects vs. Intrinsic Immune Abnormalities as Drivers of Atopic Dermatitis 
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Adiponectin: an enlarging role in acute kidney injury
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jürgen C. Becker, David Schrama  Journal of Investigative Dermatology 
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Therapeutic strategies in inflammasome mediated diseases of the liver
Macrophage heterogeneity in liver injury and fibrosis
Nat. Rev. Rheumatol. doi: /nrrheum
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Tumor Immunology Ali Al Khader, MD Faculty of Medicine
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Basophils and mast cells in renal injury
Benjamin Lockshin, MD, Yevgeniy Balagula, MD, Joseph F
Pathogenesis of allergic rhinitis
The Biology of Intestinal Immunoglobulin A Responses
Vaccines for Lung Cancer
Figure 1. Cross talk between the immune system and osteoclasts in osteoclastogenesis. Osteoclasts are derived from monocyte precursor cells. RANKL from.
Plasmacytoid Dendritic Cells in Melanoma: Can We Revert Bad into Good?
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Something in the Air: Hyperoxic Conditioning of the Tumor Microenvironment for Enhanced Immunotherapy  Robert D. Leone, Maureen R. Horton, Jonathan D.
Presentation transcript:

Autoimmune hepatitis – Update 2015 Michael P. Manns, Ansgar W. Lohse, Diego Vergani  Journal of Hepatology  Volume 62, Issue 1, Pages S100-S111 (April 2015) DOI: 10.1016/j.jhep.2015.03.005 Copyright © 2015 Terms and Conditions

Fig. 1 Molecular pathogenesis of autoimmune hepatitis. An autoantigenic peptide is presented to an uncommitted T helper (Th0) lymphocyte within the HLA class II molecule of an antigen-presenting cell (APC). Th0 cells become activated and, according to the cytokines present in the microenvironment and the nature of the antigen, differentiate into Th1, Th2, or Th17 cells, initiating a series of immune reactions determined by the cytokines they produce: Th2 secrete mainly IL-4, IL-10, and IL-13, and direct autoantibody production by B lymphocytes; Th1 secrete IL-2 and IFN-γ, which stimulate cytotoxic T lymphocytes (CTL), enhance expression of class I and induce expression of class II HLA molecules on hepatocytes and activate macrophages; activated macrophages (MØ) release IL-1 and tumour necrosis factor alpha (TNF-α). Regulatory T cells (Treg) are derived from Th0 in the presence of transforming growth factor (TGF-β). If Tregs do not oppose, a variety of effector mechanisms can be activated: liver cell destruction could derive from the action of CTL; cytokines released by Th1 and recruited macrophages; complement activation or engagement of Fc receptor-bearing cells such as natural killer (NK) lymphocytes by the autoantibody bound to the hepatocyte surface. The role of the recently described Th17 cells, which arise in the presence of TGF-β transforming growth factor beta (TGF-β) and IL-6, is under investigation. Of note, TGF-β is highly expressed in the inflamed liver, dwindling during remission [67]. Journal of Hepatology 2015 62, S100-S111DOI: (10.1016/j.jhep.2015.03.005) Copyright © 2015 Terms and Conditions

Fig. 2 Indirect immunofluorescence pattern of anti-nuclear (ANA) (left panel) and smooth muscle (SMA) (right panel) autoantibodies. Immunofluorescence pattern of anti-nuclear autoantibody (ANA) on rodent liver and Hep2 cells (inset), which, having a large nucleus, allow pattern recognition. The homogeneous pattern is the most common in autoimmune hepatitis. Immunofluorescence pattern of smooth muscle (SMA) autoantibody on rodent kidney. SMA stains the smooth muscle of arterial vessels (V) and the glomeruli (G). Journal of Hepatology 2015 62, S100-S111DOI: (10.1016/j.jhep.2015.03.005) Copyright © 2015 Terms and Conditions

Fig. 3 Immunofluorescence pattern of anti-liver kidney microsomal type 1 antibody (anti-LKM-1) (left and middle panel) and anti-liver cytosol type 1 antibody (anti-LC-1). Immunofluorescence pattern of anti-liver kidney microsomal type 1 (LKM1) autoantibody on liver and renal rodent sections: anti-LKM1 stains the cytoplasm of hepatocytes and proximal renal tubules. Immunofluorescence pattern of anti-liver cytosol type 1 (anti-LC1) antibody on a rodent liver section: the antibody stains the cytoplasm of hepatocytes with a weakening of the staining around the central vein. Journal of Hepatology 2015 62, S100-S111DOI: (10.1016/j.jhep.2015.03.005) Copyright © 2015 Terms and Conditions

Fig. 4 Liver histology showing typical features of autoimmune hepatitis as described in [61]. (A) Typical histopathology of autoimmune hepatitis with portal/periportal predominance of necroinflammatory lesion and broad interface hepatitis. (B) Emperipolesis with a lymphocyte in the cytoplasm of a damaged hepatocyte. (C) Typical rosetting of hepatocytes in the area of interface hepatitis. Histopathology pictures were provided by Hans Peter Dienes, University of Vienna, Austria. Journal of Hepatology 2015 62, S100-S111DOI: (10.1016/j.jhep.2015.03.005) Copyright © 2015 Terms and Conditions

Fig. 5 Therapeutic algorithm for autoimmune hepatitis when starting with prednisolone monotherapy [54]. Journal of Hepatology 2015 62, S100-S111DOI: (10.1016/j.jhep.2015.03.005) Copyright © 2015 Terms and Conditions

Journal of Hepatology 2015 62, S100-S111DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 Terms and Conditions